2020
DOI: 10.1371/journal.pone.0235875
|View full text |Cite
|
Sign up to set email alerts
|

Evaluating the appropriate oral lipid tolerance test model for investigating plasma triglyceride elevation in mice

Abstract: The oral lipid tolerance test (OLTT) has been known to assess intestinal fat metabolism and whole-body lipid metabolism, but rodent models for OLTT are not yet established. Differences in OLTT methodology preclude the generation of definitive results, which may cause some confusion about the anti-hypertriglyceridemia effects of the test materials. To standardize and generate more appropriate methodology for the OLTT, we examined the effects of mice strain, dietary lipid sources, fasting period, and gender on l… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 47 publications
0
4
0
Order By: Relevance
“… 46 It is reported that ASP, which constitutes the predominant form of circulating C3a, can substantially stimulate the TG synthesis and glucose transport in adipose tissue. 47 , 48 Besides, the C3a and ASP are closely related to the development of NAFLD and hepatic inflammation. 25 , 49 In agreement with these studies, the concentrations of serum CFD and its direct cleavage product C3a increased in h HNF1A mut/- mice.…”
Section: Discussionmentioning
confidence: 99%
“… 46 It is reported that ASP, which constitutes the predominant form of circulating C3a, can substantially stimulate the TG synthesis and glucose transport in adipose tissue. 47 , 48 Besides, the C3a and ASP are closely related to the development of NAFLD and hepatic inflammation. 25 , 49 In agreement with these studies, the concentrations of serum CFD and its direct cleavage product C3a increased in h HNF1A mut/- mice.…”
Section: Discussionmentioning
confidence: 99%
“…Based on previous clinical trials [19] and pancreatic lipase activity tests, it would be assumed that the consumption of ABE is likely to induce fewer adverse effects when compared to direct inhibitory agents like orlistat. Additionally, we assessed the fat trapping ability of ABE in vivo using an oral lipid tolerance test (OLTT), a standardized method to evaluate the body's ability to digest and absorb dietary fats [37]. Administration of ABE dose-dependently reduced both AUC and maximum plasma levels of postprandial triglyceride and cholesterol, showing statistically significant differences compared to the LC group (Figure 2).…”
Section: Discussionmentioning
confidence: 99%
“…Experiment 1: α-LA or EPA was administered to mice using the oral lipid tolerance test protocol reported by Ochiai et al with some modifications [20]. Briefly, 15 male ICR mice aged 8 weeks that were consuming the control LS diet were randomly allocated to three groups: an α-LA group (3 g/kg body), an EPA group (3 g/kg), and a water group (3 mL/kg).…”
Section: Experimental Designmentioning
confidence: 99%